Atefeh Arab - Concepedia

Author

Atefeh Arab

Mashhad University of Medical Sciences

Also Known As

A. A. Abou-Arab Arab, A. Arab, Atefeh Arab, Attia Arab

Publications

750

Citations

H-Index

Concepts

All Affiliations

Mashhad University of Medical Sciences Biotechnology Research Center Tehran University of Medical Sciences Shahid Beheshti University of Medical Sciences University of Waterloo

About

Atefeh Arab is an author at Mashhad University of Medical Sciences specializing in medicine, nanomedicine, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	230
2	Engineering	6	6	198
3	Biomedical Engineering	2	2	77
4	Natural Sciences	1	1	34
5	Allergy	1	1	53

Atefeh Arab

Publications

393

Citations

H-Index

Page 1

	Year	Citations
Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model Atefeh Razazan, Javad Behravan, Atefeh Arab, PLoS ONE Therapeutic Delivery SystemNanotherapeuticsEngineeringImmunologyImmunotherapeutics	2017	53
A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice Atefeh Arab, Javad Behravan, Atefeh Razazan, Journal of drug targeting	2017	46
Smart aptamer-modified calcium carbonate nanoparticles for controlled release and targeted delivery of epirubicin and melittin into cancer cells <i>in vitro</i> and <i>in vivo</i> Rezvan Yazdian‐Robati, Atefeh Arab, Mohammad Ramezani, Drug Development and Industrial Pharmacy NanoparticlesNanotherapeuticsEngineeringTargeted DeliveryBiomedical Engineering	2019	44
Lambda bacteriophage nanoparticles displaying GP2, a HER2/neu derived peptide, induce prophylactic and therapeutic activities against TUBO tumor model in mice Atefeh Razazan, Jessica Nicastro, Roderick Slavcev, Scientific Reports	2019	38
Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8+ T response Atefeh Arab, Jessica Nicastro, Roderick Slavcev, Immunologic Research Natural SciencesPeptide EngineeringImmunologyMolecular BiologyPeptide Therapeutic	2017	34
Design, synthesis and biological evaluation of 7-(aryl)-2,3-dihydro-[1,4]dioxino[2,3-g]quinoline derivatives as potential Hsp90 inhibitors and anticancer agents Sina Omid Malayeri, Khalil Abnous, Atefeh Arab, Bioorganic & Medicinal Chemistry	2017	33
P435 HER2/neu-derived peptide conjugated to liposomes containing DOPE as an effective prophylactic vaccine formulation for breast cancer Niloofar Farzad, Nastaran Barati, Amir Abbas Momtazi‐Borojeni, Artificial Cells Nanomedicine and Biotechnology VaccinationNanomedicineNanoliposome FormulationEngineeringPolymer-drug Conjugate	2019	33
Immunogenicity and antitumor activity of the superlytic λF7 phage nanoparticles displaying a HER2/neu-derived peptide AE37 in a tumor model of BALB/c mice Nastaran Barati, Atefeh Razazan, Jessica Nicastro, Cancer Letters Her2/neu-derived Peptide Ae37Tumor ModelPeptide EngineeringImmunologyPeptide Therapeutic	2018	32
Nanoliposomes carrying HER2/neu-derived peptide AE36 with CpG-ODN exhibit therapeutic and prophylactic activities in a mice TUBO model of breast cancer Nastaran Barati, Amin Reza Nikpoor, Atefeh Razazan, Immunology Letters Her2/neu-derived Peptide Ae36NanomedicineEngineeringMice Tubo ModelPeptide Engineering	2017	29
Preparation of nanoliposomes containing HER2/neu (P5+435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer Laleh Naghibi, Mona Yazdani, Amir Abbas Momtazi‐Borojeni, PLoS ONE NanoparticlesEngineeringImmunologyImmunotherapeuticsImmune System	2020	20

Page 1